drugset / Trial / NCT05214196

The Efficacy of Oral Antiseptics Against COVID-19

NCT05214196

Phase 4 Completed 75 enrolled Ataturk University
RandomizedParallel-groupTriple-blindSupportive care

Summary

In a study conducted on 75 COVID-19 patients, the effect of SARS-CoV-2 on viral load was investigated as a result of the use of hypochlorous acid and povidone-iodine as an oral antiseptic.

Timeline

Start
2021-09-01
Primary completion
2021-12-01
Completion
2021-12-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Hypochlorous acid Other / unclassified 0.02 % Oral
Subject Hypochlorous acid Other / unclassified 20 ml Oral
Subject Povidone-Iodine Other / unclassified 0.5 % Oral
Subject Povidone-Iodine Other / unclassified 20 ml Oral

Indications